Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Intrathecal Aldurazyme for Cognitive Decline in MPS I
NCT02232477Terminated
- Start
- Aug 2014
- Primary completion
- Feb 2020
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of laronidase in mucopolysaccharidosis type I. Primary endpoint: Hopkins Verbal Learning Test. Started Aug 2014; status: terminated.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on NCT02232477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232477.